Selected Drugs Clear All
MultiCheck Results
- 0
Interaction
Additional Considerations |
||
|
adalimumab
in Simlandi (adalimumab-ryvk)
|
||
|
caution advised with narrow therapeutic index drugs; chronic inflammatory conditions may alter metabolic enzyme formation; tx with immune modulators may reverse this effect, resulting in altered levels of concomitant drugs |
||
|
lactobacillus
in Lactinex
|
||
|
separate administration from antibiotics by at least 2h; combo may alter lactobacillus probiotic efficacy |
||